Mr Duncan Allardyce
| Name | Mr Duncan Allardyce |
|---|---|
| Job title | Lecturer in Chemistry/Biochemistry |
| Research institute | |
| Primary appointment | Natural Sciences |
| Email address | d.allardyce@mdx.ac.uk |
| ORCID | https://orcid.org/0000-0001-7895-2640 |
| Contact category | Researcher |
Employment
Associate lecturer in Biosciences
Middlesex University
01 Oct 2016
01 Jan 2020
Lecturer in Chemistry/Biochemistry
Middlesex University
01 Jan 2020
Education and qualifications
Grants
Prizes and Awards
Research outputs
Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold
Allardyce, D., Adu Mantey, P., Szalecka, M., Nkwo, R. and Loizidou, E. 2023. Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold. RSC Medicinal Chemistry. 14 (3), pp. 573-582. https://doi.org/10.1039/D2MD00404FIntentionality for inclusivity - the journey at Middlesex University
Roberts, H., Punev, I., Allardyce, D., Kyprianou, A., Appiah, S., Megeney, A., Calin, A., Gallacher, D. and Mill, R. 2022. Intentionality for inclusivity - the journey at Middlesex University. McGraw Hill.Argyrin B a non-competitive inhibitor of the human immunoproteasome exhibiting preference for β1i
Allardyce, D., Bell, C. and Loizidou, E. 2019. Argyrin B a non-competitive inhibitor of the human immunoproteasome exhibiting preference for β1i. Chemical Biology and Drug Design. 94 (2), pp. 1556-1567. https://doi.org/10.1111/cbdd.13539Biochemical and computational studies towards selective inhibition of the immunoproteasome
Allardyce, D. 2018. Biochemical and computational studies towards selective inhibition of the immunoproteasome. Masters thesis Middlesex University Natural SciencesAnalysis of argyrin B binding at constitutive and immunoproteasome active sites using molecular modelling and kinetic assays
Allardyce, D., Bell, C. and Loizidou, E. 2017. Analysis of argyrin B binding at constitutive and immunoproteasome active sites using molecular modelling and kinetic assays. Computational Advances in Drug Discovery (Structure Based Drug Design). Lausanne, Switzerland 05 - 08 Sep 2017241
total views of outputs22
total downloads of outputs7
views of outputs this month2
downloads of outputs this month